Stonepine Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $27.4M | Buy |
|
|||||
|
2022
Q4 | $29.7M | Sell |
|
|||||
|
2022
Q3 | $33M | Buy |
|
|||||
|
2022
Q2 | $22M | Sell |
|
|||||
|
2022
Q1 | $21.9M | Sell |
|
|||||
|
2021
Q4 | $21.8M | Buy |
|
|||||
|
2021
Q3 | $23.5M | Buy |
|
|||||
|
2021
Q2 | $19.1M | Buy |
|
|||||
|
2021
Q1 | $9.58M | Buy |
|
|||||
|
2020
Q4 | $6.61M | Sell |
|
|||||
|
2020
Q3 | $8.1M | Sell |
|
|||||
|
2020
Q2 | $4.72M | Sell |
|
|||||
|
2020
Q1 | $5.92M | Buy |
|
|||||
|
2019
Q4 | $5.93M | Buy |
|
|||||
|
2019
Q3 | $3.11M | Sell |
|
|||||
|
2019
Q2 | $3.35M | Sell |
|
|||||
|
2019
Q1 | $3.88M | Sell |
|
|||||
|
2018
Q4 | $4.2M | Buy |
|
|||||
|
2018
Q3 | $11.5M | Buy |
|
|||||
|
2018
Q2 | $20.2M | Sell |
|
|||||
|
2018
Q1 | $20.1M | Buy |
|
|||||
|
2017
Q4 | $4.92M | Buy |
|
|||||
|
2017
Q3 | $3.17M | Sell |
|
|||||
|
2017
Q2 | $7.56M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $1.07M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.99M | Sell |
|
|||||
|
2015
Q4 | $13.2M | Buy |
|